Stroke in SARS-CoV-2 Infection : A Pictorial Overview of the Pathoetiology
Copyright © 2021 Aghayari Sheikh Neshin, Shahjouei, Koza, Friedenberg, Khodadadi, Sabra, Kobeissy, Ansari, Tsivgoulis, Li, Abedi, Wolk and Zand..
Since the early days of the pandemic, there have been several reports of cerebrovascular complications during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Numerous studies proposed a role for SARS-CoV-2 in igniting stroke. In this review, we focused on the pathoetiology of stroke among the infected patients. We pictured the results of the SARS-CoV-2 invasion to the central nervous system (CNS) via neuronal and hematogenous routes, in addition to viral infection in peripheral tissues with extensive crosstalk with the CNS. SARS-CoV-2 infection results in pro-inflammatory cytokine and chemokine release and activation of the immune system, COVID-19-associated coagulopathy, endotheliitis and vasculitis, hypoxia, imbalance in the renin-angiotensin system, and cardiovascular complications that all may lead to the incidence of stroke. Critically ill patients, those with pre-existing comorbidities and patients taking certain medications, such as drugs with elevated risk for arrhythmia or thrombophilia, are more susceptible to a stroke after SARS-CoV-2 infection. By providing a pictorial narrative review, we illustrated these associations in detail to broaden the scope of our understanding of stroke in SARS-CoV-2-infected patients. We also discussed the role of antiplatelets and anticoagulants for stroke prevention and the need for a personalized approach among patients with SARS-CoV-2 infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Frontiers in cardiovascular medicine - 8(2021) vom: 10., Seite 649922 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aghayari Sheikh Neshin, Saeideh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood coagulation |
|---|
| Anmerkungen: |
Date Revised 23.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fcvm.2021.649922 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324098693 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324098693 | ||
| 003 | DE-627 | ||
| 005 | 20231225185608.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fcvm.2021.649922 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1080.xml |
| 035 | |a (DE-627)NLM324098693 | ||
| 035 | |a (NLM)33855053 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Aghayari Sheikh Neshin, Saeideh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Stroke in SARS-CoV-2 Infection |b A Pictorial Overview of the Pathoetiology |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2021 Aghayari Sheikh Neshin, Shahjouei, Koza, Friedenberg, Khodadadi, Sabra, Kobeissy, Ansari, Tsivgoulis, Li, Abedi, Wolk and Zand. | ||
| 520 | |a Since the early days of the pandemic, there have been several reports of cerebrovascular complications during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Numerous studies proposed a role for SARS-CoV-2 in igniting stroke. In this review, we focused on the pathoetiology of stroke among the infected patients. We pictured the results of the SARS-CoV-2 invasion to the central nervous system (CNS) via neuronal and hematogenous routes, in addition to viral infection in peripheral tissues with extensive crosstalk with the CNS. SARS-CoV-2 infection results in pro-inflammatory cytokine and chemokine release and activation of the immune system, COVID-19-associated coagulopathy, endotheliitis and vasculitis, hypoxia, imbalance in the renin-angiotensin system, and cardiovascular complications that all may lead to the incidence of stroke. Critically ill patients, those with pre-existing comorbidities and patients taking certain medications, such as drugs with elevated risk for arrhythmia or thrombophilia, are more susceptible to a stroke after SARS-CoV-2 infection. By providing a pictorial narrative review, we illustrated these associations in detail to broaden the scope of our understanding of stroke in SARS-CoV-2-infected patients. We also discussed the role of antiplatelets and anticoagulants for stroke prevention and the need for a personalized approach among patients with SARS-CoV-2 infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a blood coagulation | |
| 650 | 4 | |a neuroimmunomodulation | |
| 650 | 4 | |a pathophysiology | |
| 650 | 4 | |a pharmacology | |
| 650 | 4 | |a renin-angiotensin system | |
| 650 | 4 | |a stroke | |
| 700 | 1 | |a Shahjouei, Shima |e verfasserin |4 aut | |
| 700 | 1 | |a Koza, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Friedenberg, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Khodadadi, Faezeh |e verfasserin |4 aut | |
| 700 | 1 | |a Sabra, Mirna |e verfasserin |4 aut | |
| 700 | 1 | |a Kobeissy, Firas |e verfasserin |4 aut | |
| 700 | 1 | |a Ansari, Saeed |e verfasserin |4 aut | |
| 700 | 1 | |a Tsivgoulis, Georgios |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Jiang |e verfasserin |4 aut | |
| 700 | 1 | |a Abedi, Vida |e verfasserin |4 aut | |
| 700 | 1 | |a Wolk, Donna M |e verfasserin |4 aut | |
| 700 | 1 | |a Zand, Ramin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in cardiovascular medicine |d 2014 |g 8(2021) vom: 10., Seite 649922 |w (DE-627)NLM255534736 |x 2297-055X |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g day:10 |g pages:649922 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fcvm.2021.649922 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 |b 10 |h 649922 | ||